Abbott signs agreement to market 24 Zydus Cadila products

12 May 2010

1

US-based drug maker Abbott has announced a licensing and supply agreement to sell 24 with Zydus Cadila drugs in 15 emerging markets in a bid to accelerate its emerging markets growth.

However, the financial terms of the agreement were not disclosed nor the products that Abbott will market for Zydus.

Under the agreement, Abbott will gain marketing rights for the  Zydus products in high-growth emerging where Abbott says it has a strong and growing presence.

According to Abbott, the agreement also includes an option for the addition of more than 40 Zydus products to the collaboration.

"Branded generics represent the most significant growth opportunity in emerging markets," said Abbott.

Product launches under the collaboration are expected to begin in early 2012, it added.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more